← Eichor
Study identifier: NCT06964685 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Condition: AMI Cardiogenic Shock  ·  Sponsor: Abiomed Inc.

PhaseN/A
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The observational study titled "Observational Assessment of Support with Impella Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock (OASIS-AMICS)" aims to evaluate the safety outcomes of patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) who receive Impella CP during percutaneous coronary intervention (PCI) and who are managed with Impella best practices while receiving guideline-directed standard of care. This prospective, multicenter study will enroll up to 350 hemodynamically unstable patients with cardiogenic shock of less than 12 hours duration and acute myocardial infarction (AMI) of less than 24 hours duration. Cardiogenic shock will be confirmed by tissue hypoperfusion (lactate ≥ 2.5mmol/L and/or SvO2 \<55% with a normal PaO2) and systolic blood pressure \<100 mmHg and/or need for vasopressor therapy (dopamine/norepinepherine or epinephrine). Patients will be assessed for various safety endpoints, including a composite safety endpoint involving major bleeding, acute limb ischemia, and acute kidney injury. Secondary endpoints will evaluate all-cause mortality, major adverse cardiovascular and cerebrovascular events (MACCE), and hospitalizations through 1-year post-Impella implant. All patients presenting with AMICS at study sites will be screened for inclusion in the study after hospital discharge (or after death, if prior to hospital discharge). IRB approved consent waiver will be used to collect data from el…

This description comes directly from the study's public registry record.

Talk to the study team

Sameera Dasari, PhD  ·  978-914-8882  ·  sdasar12@its.jnj.com

Always discuss trial participation with your own doctor first.

Locations (18)

Cardiology Associates Research Group (St. Bernard's Hospital)Jonesboro, Arkansas, United StatesRecruiting
St. Joseph Hospital OrangeOrange, California, United StatesRecruiting
Torrance Memorial Medical CenterTorrance, California, United StatesRecruiting
NCH Rooney Heart InstituteNaples, Florida, United StatesRecruiting
Straub Benioff Medical CenterHonolulu, Hawaii, United StatesRecruiting
OSF Saint FrancisPeoria, Illinois, United StatesRecruiting
Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting
Henry Ford Health SystemDetroit, Michigan, United StatesRecruiting
New Mexico HeartAlbuquerque, New Mexico, United StatesRecruiting
Bethesda North HospitalCincinnati, Ohio, United StatesRecruiting
Saint Francis HospitalTulsa, Oklahoma, United StatesRecruiting
Providence St. Vincent Medical CenterPortland, Oregon, United StatesRecruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06964685